Follow us on:

©2019-2020 by Wavegate Technologies, LLC.

StimuLux (TM) Technology is covered under Patents 8,239,038; 8,543,213; 9,132,273; 9,550,063; 9,656,097; 9,821,161; 10,035,019; AU2015203820; EP2627399; AU2011314383; CA2814477; WO2012050619.  Additional patents pending.

  • Wavegate Technologies

Wavegate Management Team Adds Strategic Advisors

March 7, 2020- Lake Charles, LA. Wavegate Technologies is pleased to announce the addition of Kevin T. Foley, MD, Cedric F. Walker, PhD, and Mark S. Faucett to the management team as strategic advisors. Dr. Foley has an extensive track record of medical device innovation and commercialization success. Dr. Walker brings expertise in regulatory affairs and manufacturing as they pertain to neuromodulation. Mr. Faucett is a seasoned veteran of medical device sales and marketing.

We enthusiastically welcome our strategic advisors as we engage to bring transformative pain relief to our patients through StimuLux adaptive stimulation technology.